BioMarin eyes first profits in 2022 as dwarfism drug launch kicks into gear, hemophilia gene therapy refiling nears aliu Thu, 02/24/2022 – 10:12 More: BioMarin eyes first profits in 2022 as dwarfism drug launch kicks into gear, hemophilia gene therapy
read moreNo sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial More: Data from first DMT-assisted clinical trial revealed Source: News
read morePharma giants take major stride as vaccine shows significant increase in neutralising antibodies More: Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine Source: News
read more‘Major blunder:’ Ex-staffers blast Bristol Myers Squibb’s handling of Breyanzi approval in latest CVR lawsuit update fkansteiner Wed, 02/23/2022 – 11:57 More: 'Major blunder:' Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update Source: fierce
read moreNovavax begins delivery of its long-delayed COVID-19 vaccine in Europe kdunleavy Wed, 02/23/2022 – 11:14 More: Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe Source: fierce
read moreGearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with $85M for key launch aliu Wed, 02/23/2022 – 10:42 More: Gearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with M for key launch
read more© 1994 - 2026 B.M. Pharmaceuticals